Psychedelic therapeutics stocks
Heavily traded in Psychedelic therapeutics
Turnover over $10M/day5 of about 20 companies in this theme turn over more than $10M in a typical session. Largest market value first. Data as of Oct 30, 2026.
| Company | Turnover | 1Y return | Next report |
|---|---|---|---|
| MMEDMiniMed Group, Inc. | $59.93M | +4.11% | Nov 16, 2026 |
| DFTXDefinium Therapeutics, Inc. | $72.94M | +194.04% | Reports Nov 5, 2026 |
| ATAIAtaiBeckley Inc. | $67.49M | +25.43% | Reports Nov 12, 2026 |
| CMPSCOMPASS Pathways plc | $29.77M | +92.58% | Reports Nov 3, 2026 |
| HELPCybin D/B/A Helus Pharma | $15.71M | +43.18% | Reports Nov 12, 2026 |
Turnover is the median value traded in one session, measured over the past 50 sessions. It describes trading activity in a stock and nothing about the company behind it.
Table
15 companies, largest market value first.
Data as of Oct 30, 2026 · updates nightly, Mon–Sat
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| MMED | MiniMed Group, Inc. | $5.40B | Mid cap | +4.11% |
| DFTX | Definium Therapeutics, Inc. | $5.10B | Mid cap | +194.04% |
| ATAI | AtaiBeckley Inc. | $2.73B | Mid cap | +25.43% |
| CMPS | COMPASS Pathways plc | $1.69B | Small cap | +92.58% |
| GHRS | GH Research PLC | $1.48B | Small cap | +56.14% |
| HELP | Cybin D/B/A Helus Pharma | $782.58M | Small cap | +43.18% |
| CAQ | Cambridge Acquisition Corp. | $312.59M | Small cap | +0.81% |
| ENP.AX | Entropy Neurodynamics Limited | $34.50M | Micro cap | −18.92% |
| IXHL | Incannex Healthcare Inc. | $32.37M | Micro cap | −74.93% |
| EMD.AX | Emyria Limited | $22.14M | Micro cap | −35.00% |
| PBM | Psyence Biomedical Ltd. | $12.97M | Micro cap | −97.19% |
| ENVB | Enveric Biosciences, Inc. | $6.53M | Micro cap | −78.21% |
| XTLB | XTL Biopharmaceuticals Ltd. | $4.33M | Micro cap | −63.03% |
| CMND | Clearmind Medicine Inc. | $2.97M | Micro cap | −98.54% |
| SILO | Silo Pharma, Inc. | $2.95M | Micro cap | +132.34% |
Covers ~23,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Price and the 52-week distance are in the currency the stock trades in; only market values are converted.
We cover 15 companies grouped under the Psychedelic therapeutics theme. The median market value in the group is $34.50M. Among the 12 with a price from the latest session, the median move over the past trading day is −0.71%. Price change over the past year runs from −89.6% to +116.4% across the middle 80 percent of the group, with a median of +0.8%.